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Abstract
Background: Oxytocin is an important neuromodulator involved in cognition and socio-emotional processing that
exerts its central activities via oxytocin receptors. Epigenetic alterations in the oxytocin receptor gene (OXTR) may
be a molecular mechanism in the pathogenesis of obsessive-compulsive disorder (OCD). This study investigated the
association between OXTR DNA methylation and the OCD status of a Korean population.
Results: Quantitative leukocyte DNA methylation levels of three cytosine-phosphate-guanine (CpG) sites in the 5′
untranslated region (UTR) of OXTR exon 2 and eight CpG sites within OXTR exon 3 were analyzed using the pyrosequencing
method in 151 patients with OCD (including 45 drug-naïve patients) and 108 healthy controls. DNA methylation levels were
compared between the groups using multiple analyses of covariance separately by sex after controlling for age and
educational level. Patients with OCD showed significantly lower methylation levels at CpG1 and CpG2 sites on the UTR of
OXTR exon 2 than those of healthy controls for both sexes. In a subset of 45 drug-naïve patients with OCD, the DNA
methylation levels also remained significantly lower than those in the controls and their CpG1 methylation levels were
significantly negatively associated with the ordering symptom dimension.
Conclusions: Our findings suggest that epigenetic OXTR alterations may affect the pathophysiology of OCD. The potential
role of the oxytocin system in OCD development and treatment warrants further investigation.
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Background
Oxytocin is an important neuropeptide that regulates so-
cial behaviors and is involved in various cognitive and
emotional processes [1, 2]. Since oxytocin exerts its cen-
tral activities via oxytocin receptors (OXTR) in the brain,
studying alterations in OXTR is of great importance for
understanding the molecular mechanisms underlying the
pathogenesis of psychiatric conditions related to socio-
emotional processing [3–5]. DNA methylation, an epigen-
etic mechanism by which cells dynamically control gene
expression without changing the DNA sequence, has
emerged as a crucial mechanism underlying the inter-
action between genetic background and environmental
factors in the development of psychiatric disorders [6]. It
has been reported that differential OXTR DNA methyla-
tion is involved in various psychological functions relevant
to psychopathology including callous-unemotional traits
[7], social perception [8], and resilience [9] and is also in-
volved in psychiatric illnesses such as autism spectrum
disorder (ASD) [4], postpartum depression [10], social
anxiety disorder [11], and early-stage schizophrenia [12].
Epigenetic alterations in the OXTR gene are a promis-
ing candidate marker for mediating genetic susceptibility
to obsessive-compulsive disorder (OCD), which is char-
acterized by recurrent and disturbing obsessions and re-
petitive compulsive behaviors. OCD is known to develop
© The Author(s). 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License,
which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give
appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if
changes were made. The images or other third party material in this article are included in the article's Creative Commons
licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons
licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain
permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the
data made available in this article, unless otherwise stated in a credit line to the data.
* Correspondence: jeeinkang@yuhs.ac; kimsejoo@yuhs.ac
2Department of Psychiatry, Yonsei University College of Medicine, Yonsei-ro
50-1, Seodaemun-gu, Seoul 03722, Republic of Korea
Full list of author information is available at the end of the article
Park et al. Clinical Epigenetics          (2020) 12:101 
https://doi.org/10.1186/s13148-020-00890-w
via complex interactions between genetic and environ-
mental factors [13]. The oxytocin system has been impli-
cated as having a role in the pathogenesis and treatment
of OCD [14]; however, little research has been carried
out on the epigenetics of OXTR in OCD. Studies of the
oxytocin system in OCD have primarily focused on
changes in oxytocin levels [15, 16] and the DNA se-
quence without considering the role of epigenetic factors
[17]. Recently, an epigenetic study with a small sample
size showed that OXTR hypermethylation was associated
with OCD susceptibility and symptom severity [18].
Given the emerging role of OXTR in OCD pathogenesis,
investigating epigenetic OXTR alterations may be im-
portant for understanding the molecular mechanisms
underlying OCD pathogenesis and discovering better
biomarkers for OCD development and progression.
In this study, we investigated differences in the
leukocyte DNA methylation level of OXTR between pa-
tients with OCD and healthy controls. To exclude the
potential effects of medication on DNA methylation in
patients with OCD, we examined whether the results of
the whole cohort were confirmed in a subgroup of drug-
naïve patients with OCD. Moreover, we examined how
DNA methylation levels at specific OXTR cytosine-
phosphate-guanine (CpG) sites were associated with
symptom severity and OCD dimensions.
Results
Demographics and clinical characteristics
The demographics and clinical features of each group
are presented in Table 1. There were significant differ-
ences in the DNA methylation levels of several OXTR1
and OXTR2 CpG sites between men and women.
Women in the control group showed higher DNA
methylation levels at OXTR1 CpG1 (t = − 2.40, p =
0.018) and CpG2 (t = − 2.83, p = 0.006). Similarly,
women in the OCD group showed hypermethylation at
all three OXTR1 sites compared to the men: CpG1 (t =
− 2.08, p = 0.039), CpG2 (t = − 2.80, p = 0.006), and
CpG3 (t = − 2.27, p = 0.025). For OXTR2, there was no
significant difference between women and men in either
the control or patient groups.
Group differences in OCD status due to OXTR DNA
methylation
As shown in Table 2, multivariate analysis of covariance
(MANCOVA) revealed that OCD status had a significant
overall effect on DNA methylation levels in both men
(Wilks λ = 0.822, F(4, 161) = 8.693, p < 0.001) and women
(Wilks λ = 0.736, F(4, 84) = 7.525, p < 0.001). Post hoc
comparisons using Bonferroni-adjusted alpha for the
four dependent variables indicated that patients with
OCD had significantly lower methylation levels at
OXTR1 CpG1 and CpG2 sites and no significant differ-
ence at OXTR1 CpG3 compared to healthy controls for
both men and women. No significant findings were
found for OXTR2 methylation levels.
When the same analysis was carried out on a subset of
drug-naïve subjects to exclude the potential effects of
medication on DNA methylation levels, the significant
OXTR findings were still significant in both sexes. MAN-
COVA revealed significant overall effects on the affective
status of OCD in men (Wilks λ = 0.840, F(4, 81) = 3.843,
p = 0.007) and women (Wilks λ = 0.666, F(4, 58) = 7.285,
p < 0.001) in OXTR1, but not in OXTR2. Drug-naïve pa-
tients with OCD showed significantly lower levels of
DNA methylation at CpG1 (men: F = 7.642, p = 0.007,
ηp
2 = 0.083; women: F = 10.389, p < 0.001, ηp
2 = 0.193)
and CpG2 (men: F = 14.633, p < 0.001, ηp
2 = 0.148;
women: F = 5.908, p = 0.002, ηp
2 = 0.147) sites than the
healthy controls in both sexes (Table 3). There was no
significant difference in the DNA methylation status be-
tween drug-naïve and drug-treated patients with OCD
for all the CpG sites in each sex (Supplementary Table
S1).
Relationships between OXTR methylation and clinical
characteristics of OCD
Partial correlation analyses among the drug-naïve pa-
tients with OCD revealed that OCD symptom severity
Table 1 Demographics and clinical features of participants
Men Women
OCDa (n = 112) HCa (n = 56) Pb OCDa (n = 39) HCa (n = 52) Pb
Age 21.9 ± 2.2 21.5 ± 3.5 0.385 21.8 ± 2.2 21.1 ± 3.6 0.269
Education, year 12.7 ± 1.7 13.5 ± 1.7 0.006 13.1 ± 1.8 13.6 ± 1.9 0.26
Age of onset 14.3 ± 4.1 14.7 ± 4.0
Duration of illness, year 7.6 ± 4.5 7.0 ± 3.9
MADRS 20.6 ± 9.8 19.7 ± 9.7
Y-BOCS 25.0 ± 6.9 25.9 ± 6.5
OCD obsessive-compulsive disorder, HC healthy control, MADRS Montgomery-Asberg Depression Rating Scale, Y-BOCS Yale-Brown Obsessive-Compulsive Scale
aMean ± standard deviation
bIndependent samples t test
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measured by Yale-Brown Obsessive Compulsive Scale
(Y-BOCS) had no significant association with DNA
methylation levels at OXTR1 CpG1 and CpG2, which
showed a significant between-group difference (r = 0.146
and p = 0.358 for CpG1; r = -0.211 and p = 0.18 for
CpG2). Among the six OC symptom dimensions (wash-
ing, obsessing, hoarding, ordering, checking, and neu-
tralizing) measured by the Korean version of Obsessive-
Compulsive Inventory-Revised (OCI-R-K), ordering di-
mension scores were significantly and negatively corre-
lated with DNA methylation at the CpG1 site (r = −
0.422, p = 0.005; Fig. 1). Conversely, CpG1 DNA methy-
lation levels were not significantly associated with any
OCD dimensions.
Discussion
The role of epigenetic OXTR regulation via DNA
methylation in psychiatric disorders such as OCD is a
promising and relatively new field of investigation. The
key finding of this study was that both male and female
patients with OCD showed significantly altered OXTR1
methylation status. These significant findings were also
confirmed in a subset of drug-naïve patients with OCD,
suggesting that OXTR1 epigenetic alterations may play a
crucial role in the pathogenesis of OCD and act as a mo-
lecular mechanism underlying the development and re-
covery of OCD, possibly via interactions with genetic
predisposition and environmental factors.
In this study, patients with OCD exhibited DNA hypo-
methylation (which may indicate higher OXTR expres-
sion) at CpG1 (Chr3: 8,810,833) and CpG2 (Chr3: 8,810,
808) in the 5′ untranslated region (UTR) of OXTR exon
2 compared to healthy controls. To date, only one study
with a small sample size (42 patients with OCD vs. 31
controls) has reported OXTR methylation in OCD, find-
ing that hypermethylation of specific CpG sites in OXTR
exon 3 was associated with OCD disease status, correlat-
ing positively with OC symptom severity and negatively
with depressive scores [18]. Although various differences
between our study and theirs, including age and target
CpG sites, make direct comparison difficult, their find-
ings indicated that the associations of OXTR methylation









52)F pb ηp2c F pb ηp2c
Statistics: Wilks λ = 0.822, F(4, 161) = 8.693, p < 0.001 Statistics: Wilks λ = 0.736, F(4, 84) = 7.525, p < 0.001
OXTR1 (exon2) CpG1 (-959) 40.94 ± 5.17 45.67 ± 4.88 20.012 < 0.001 0.109† 42.94 ± 5.13 47.70 ± 3.89 21.784 < 0.001 0.200‡
CpG2 (-934) 46.33 ± 5.21 50.44 ± 4.52 22.873 < 0.001 0.122† 49.11 ± 5.75 52.54 ± 3.14 10.631 0.002 0.109†
CpG3 (-924) 58.08 ± 5.25 59.62 ± 3.82 1.835 0.177 0.011 60.36 ± 5.86 60.74 ± 3.75 0.032 0.858 < 0.001
OXTR2 (exon3) Mean value of CpG1-8 13.81 ± 5.46 13.34 ± 5.66 0.233 0.630 0.001 14.80 ± 4.49 14.14 ± 4.57 0.020 0.888 < 0.001
MANCOVA demonstrated significant between-group differences after controlling for age and education
MANCOVA multivariate analysis of covariance, OCD obsessive-compulsive disorder, HC healthy control
aMean ± standard deviation of raw data
bStatistical significance was set at p < 0.0125 after Bonferroni correction for the 4 CpG sites
cEffect size was calculated using partial eta squared and interpreted according to the rule of Miles and Shevlin (2001)
†Medium effect (> 0.06)
‡Large effect (> 0.14)
Table 3 Results of MANCOVA of DNA methylation at OXTR CpG sites between drug-naïve patients with OCD and healthy controls









52)F pb ηp2c F pb ηp2c
Statistics: Wilks λ = 0.840, F(4, 81) = 3.843, p = 0.007 Statistics: Wilks λ = 0.666, F(4, 58) = 7.285, p < 0.001
OXTR1 (exon2) CpG1 (-959) 41.49 ± 5.66 45.67 ± 4.88 7.642 0.007 0.083† 42.75 ± 5.96 47.70 ± 3.89 10.389 < 0.001 0.193‡
CpG2 (-934) 46.41 ± 4.73 50.44 ± 4.52 14.633 < 0.001 0.148‡ 48.87 ± 3.72 52.54 ± 3.14 5.908 0.002 0.147‡
CpG3 (-924) 57.41 ± 4.45 59.62 ± 3.82 6.044 0.016 0.067 61.49 ± 6.12 60.74 ± 3.75 0.695 0.368 0.013
OXTR2 (exon3) Mean value of CpG1-8 14.32 ± 6.31 13.34 ± 5.66 0.388 0.535 0.005 13.79 ± 4.27 14.14 ± 4.57 0.274 0.599 0.005
MANCOVA demonstrated significant between-group difference after controlling for age and education
MANCOVA multivariate analysis of covariance, OCD obsessive-compulsive disorder, HC healthy control
aMean ± standard deviation of raw data
bStatistical significance was set at p < 0.0125 after Bonferroni correction for 4 CpG sites
cEffect size was calculated using partial eta squared and interpreted according to the rule of Miles and Shevlin (2001)
†Medium effect (> 0.06)
‡Large effect (> 0.14)
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acted in the opposite direction to our findings. Com-
pared to the previous study, we believe that our study
has several advantages, including a larger sample size
and a more reliable OCD recruitment method (tertiary
hospital vs. advertisement), and our findings showed
consistent results in both male and female subjects as
well as in drug-naïve patients. Furthermore, several stud-
ies have reported similar findings from fields of psych-
iatry other than OCD; for instance, the same direction of
OXTR hypomethylation was observed in a clinical study
of ASD [19]. A recent study of early-stage schizophrenia
also demonstrated that hypomethylation status at the
same genomic OXTR position as our significant results
was associated with susceptibility to schizophrenia and
anhedonia-asociality in women [12]. A systematic narra-
tive review of OXTR DNA methylation in human socio-
emotional functioning suggested that while OXTR
hypermethylation may play a role in the general impair-
ment of socio-emotional functioning, OXTR hypomethy-
lation may play a role in specific patterns of impairment
related to psychiatric disorders, such as anxiety disorders
[3]. As proposed by Ziegler et al. who demonstrated the
relationship between OXTR exon 3 hypomethylation and
social anxiety, OXTR hypomethylation findings suggest
that higher OXTR expression might act as compensatory
upregulation for reduced oxytocin levels [11]. However,
previous studies on OCD could not conclude that al-
tered oxytocin level in cerebrospinal fluid was associated
with disease status [15, 20]. Interestingly, Marroni et al.
argued that the oxytocin receptor’s failure to respond to
oxytocin activation might be involved in the continu-
ation of compulsive behavior in their study which inves-
tigated an experimental animal model of hypergrooming
behavior [21]. In addition, some basic studies suggested
that inhibited neuronal activity induced DNA demethyl-
ation of specific receptors [22, 23]. The relationship be-
tween methylation status and dysfunctional receptor
properties or signaling in oxytocin system is still un-
known, and it may be an alternative area to investigate.
Therefore, it is crucial to elucidate the mechanisms of
interaction between OXTR methylation and oxytocin re-
ceptor dysfunction in patients with OCD in future stud-
ies. Since there is currently very limited evidence on
epigenetic OXTR regulation in psychiatric fields includ-
ing OCD and the direction of the association has been
reported to show mixed findings, further longitudinal
studies or preclinical studies are required to better estab-
lish the role of OXTR methylation in OCD pathogenesis
to determine whether altered OXTR methylation status
confers vulnerability to OCD development or is a conse-
quence of OCD.
Given the distinct neural correlates of OC symptom
dimensions [24], we examined whether the DNA methy-
lation levels at the OXTR1 CpG sites that showed a sig-
nificant between group-difference were associated with
certain symptom dimensions in drug-naïve patients with
Fig. 1 Correlation between DNA methylation levels at OXTR1 CpG1 and ordering symptom severity in drug-naïve patients with OCD (n = 45). OXTR,
oxytocin receptor gene; OCI-R-K, obsessive-compulsive inventory-revised-Korean; OCD, obsessive-compulsive disorder
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OCD. Among the six symptom dimensions assessed by
the OCI-R-K, DNA methylation levels at OXTR1 CpG1
were found to be inversely associated with ordering di-
mension scores in drug-naïve patients with OCD [25–
27]. Patients with high ordering dimension scores, char-
acterized by ordering and arranging their surroundings
and ensuring that objects are arranged in exactly the
right way, have been found to have different characteris-
tics, such as an earlier onset age, a more familial OCD
form, impaired set-switching abilities, and a dissociable
neural system [24, 28, 29]. Epigenetic OXTR regulation
may be a molecular mechanism underlying the clinical
and biological differences in the ordering dimension. Al-
though it is unclear how OXTR methylation relates spe-
cific to the symptom dimension, it is possible that the
ordering/arranging symptom dimension includes shared
clinical features of OCD and ASD [25–27] that might be
modulated by OXTR methylation. This will need to be
elucidated in further studies.
This study has several limitations to consider. Firstly,
since we cannot measure the methylation status of hu-
man brain tissue directly in a clinical study, we assumed
that the DNA methylation status of the peripheral blood
reflected that of the CNS. Although altered OXTR DNA
methylation in the blood has been shown to be signifi-
cantly associated with gene expression in brain tissue [4]
and the neural response of social and emotional process-
ing [8, 30, 31], their relationship across tissues has not
yet been clearly established. Secondly, although OXTR
methylation status have been observed to be associated
with OXTR mRNA expression [4], hormone analysis of
circulating oxytocin levels and mRNA expression of oxy-
tocin and OXTR were not evaluated in this study. Thus,
we cannot determine the functional significance of the
CpGs studied and their relationship with oxytocin levels.
Thirdly, since different genotypes may affect DNA
methylation, we could not completely rule out the po-
tential effect of different genotypes of OXTR gene on the
present results. However, we previously reported that
there was no significant difference in the genotype distri-
butions and the haplotype frequencies for 10 common
SNPs (rs1042778, rs237885, rs237887, rs2268490,
rs4686301, rs2268493, rs2254298, rs13316193, rs53576,
and rs2268498) on OXTR gene between patients with
OCD (N = 615) and healthy controls (N = 581) [17].
When we additionally examined in a subset of the
present sample with OCD (n = 129) whether the differ-
ent genotypes of the 10 SNPs of OXTR gene have differ-
ent methylation levels of OXTR1, there was no
association between OXTR SNPs and methylation levels
in the CpGs of OXTR1 (all p > 0.05). Fourthly, we did
not consider potential confounders that may affect the
DNA methylation status of the OXTR gene, such as
cigarette smoking status [32], heterogeneity of white
blood cell types [33], and exposure to environmental fac-
tors such as diet, maternal care, and lifestyle [34]. Hence,
further research that considers these potential con-
founders and gene-environment interactions are war-
ranted to confirm our results. Fifthly, we cannot
conclude whether the epigenetic OXTR alterations re-
flect specific OCD factors or shared traits with other
psychiatric disorders related to socio-emotional prob-
lems and repetitive behaviors. Lastly, our study had a
cross-sectional design; thus, conclusions cannot be
drawn regarding the causal direction of the relationships
between epigenetic alterations and OCD. To better es-
tablish the role of OXTR methylation and causal rela-
tionships in the pathogenesis and course of OCD,
further longitudinal studies are needed.
Conclusions
The present study showed altered DNA methylation sta-
tus of OXTR1 in both male and female patients with
OCD as well as in a subset of drug-naïve OCD patients,
compared to healthy controls. Our findings suggest that
epigenetic alterations of OXTR may exert an effect on
the pathophysiology of OCD. The potential role of




A total of 151 patients (112 men, 39 women) with OCD
were recruited from a specialized OCD outpatient clinic
at Severance Hospital of Yonsei University Health Sys-
tem (Seoul, Republic of Korea), a tertiary care hospital.
All patients were referred from primary care for OCD
and were assessed by trained psychiatrists using the
Structured Clinical Interview for DSM-IV-TR [35] to
confirm the existence of current or past psychiatric dis-
orders. The demographic and clinical information of the
patients were also systematically assessed. Patients were
excluded if they met the following criteria: psychiatric
disorders with psychotic symptoms, other anxiety disor-
ders, substance dependence, mental retardation (as de-
fined by DSM-IV), history of major head trauma, or
current major somatic or neurological disorders. For the
control group, we recruited 108 healthy subjects (56
men, 52 women) using posters and online advertise-
ments. According to the DSM-IV-TR diagnostic criteria,
subjects with a current or previous lifetime history of
any psychiatric disorders were excluded from the study.
All participants provided written informed consent ac-
cording to procedures approved by the Severance Hos-
pital Institutional Review Board and all methods
conformed to the approved guidelines.
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Measurement of OC symptoms and clinical characteristics
Clinical symptoms were assessed by a trained psycholo-
gist using the 10-item Y-BOCS [36] for OC symptom se-
verity and the Montgomery-Åsberg Depression Rating
Scale (MADRS) [37] for depression severity. We also
used the OCI-R-K [38, 39] to assess the severity of OC
symptoms via dimensions including washing, obsessing,
hoarding, ordering, checking, and neutralizing.
Pyrosequencing procedures
Three CpG sites in the 5′ UTR of OXTR exon 2 (OXTR1)
and eight CpG sites in the protein coding region of OXTR
exon 3 (OXTR2) were targeted based on previous studies:
OXTR1 (Chr3: 8,810,729–8,810,845; GRCh37/hg19) [30]
and OXTR2 (Chr3: 8,809,281–8,809,534; GRCh37/hg19)
[11, 40]. The OXTR1 included the CpG site -934 (relative
to translation start site) in which elevated DNA methyla-
tion level was reported to be related to decreased expres-
sion of OXTR in temporal cortex tissue of autistic males
[4], and the methylation level was revealed to be associ-
ated with brain activity in dorsal anterior cingulate cortex
which is important in OCD pathophysiology [30]. We also
targeted CpG sites in OXTR2 which were reported to have
significant relationships with response to social stress in
social phobia or non-clinical subjects [11, 40], considering
that several studies suggested an impairment of social cog-
nition in patients with OCD [41, 42]. These selected CpG
sites are shown in Fig. 2.
Genomic DNA was extracted from whole blood using
standard techniques by DNA Link, Inc. (Seoul, Republic
of Korea). The pyrosequencing procedure was used for
DNA methylation analysis by Genomictree, Inc. (Dae-
jeon, Republic of Korea). The bisulfite conversion was
conducted using the EZ DNA Methylation-Lightning kit
(Zymo Research, CA, USA). The target regions were
amplified using polymerase chain reaction (PCR) with
converted DNA, and the PCR was conducted in accord-
ance to the general guidelines of pyrosequencing.
Fig. 2 The location of CpG-rich regions in the oxytocin receptor gene and target primer sequences. The sequence is displayed according to GRCh37 build,
National Center for Biotechnology Information (NCBI) reference sequence NC_000003.11. CpG sites are numbered (OXTR1, CpG1 = Chr3: 8,810,833, CpG2 =
Chr3: 8,810,808, CpG3 = Chr3: 8,810,798; OXTR2, CpG1 = 8,809,413, CpG2 = 8,809,417, CpG3 = 8,809,422, CpG4 = 8,809,425, CpG5 = 8,809,428, CpG6 = 8,809,433,
CpG7 = 8,809,437, and CpG8 = 8,809,442)
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Successful PCR products were confirmed using electro-
phoresis on a 2% agarose gel. The pyrosequencing was
performed using a PyroMark ID system with the Pyro
Gold reagents kit (Qiagen, Hilden, Germany). To control
for the internal quality of completeness of bisulfite treat-
ment, the analysis of a non-CpG cytosine was included
during pyrosequencing. More detailed information of
these procedures have been described elsewhere [12].
Statistical analysis
All data analysis was conducted using SPSS 25 software
(IBM Corp., Armonk, NY, USA). Descriptive statistics
were calculated for demographic and clinical variables,
with continuous variables presented as the mean ±
standard deviation (SD). Differences in the demographic
data between patients with OCD and healthy controls
were assessed using t tests. Data were examined for nor-
mality by visual inspection of their histograms and the
Shapiro-Wilk test. For variables with non-normal distri-
bution, normal score with the Blom method [43] was
used for group comparisons. Since the DNA methylation
levels were not normally distributed, Blom transform-
ation was applied. The distributions of the raw data of
methylation levels of individual CpGs (Supplementary
Fig. 1) and a description of the normalization process
are included in the supplementary material.
MANCOVA was conducted to evaluate the influence of
OCD status on OXTR1 and OXTR2 DNA methylation
levels with covariates of age and education level. Given
that oxytocin system function is sexually dimorphic [44–
46], we conducted the analyses separately for men and
women. Since DNA methylation levels at the eight OXTR2
CpG sites were highly intercorrelated (Cronbach’s alpha,
men with OCD 0.99, women with OCD 0.985, control
men 0.981, control women 0.975), the average methyla-
tion level of the eight CpG sites was used as a variable for
the analyses. Thus, we used the DNA methylation levels at
four CpG sites (three OXTR1 CpGs and one averaged
value for 8 OXTR2 CpGs) as dependent variables in the
MANCOVA model. Additionally, to rule out potential ef-
fects of medication, we compared the DNA methylation
status between drug-naïve patients and healthy controls,
and drug-naïve and drug-treated patients using MAN-
COVA. Statistical significance was adjusted for the mul-
tiple comparisons of the four CpG sites using the
Bonferroni method (α = 0.0125).
To investigate the relationships between OXTR DNA
methylation levels and clinical OCD characteristics as
measured by Y-BOCS and OCI-R-K, partial correlation
coefficients were calculated, controlling for the potential
confounding effects of sex, age, and MADRS score. Par-
tial correlation coefficients were used for drug-naïve pa-
tients with OCD (n = 45) to exclude the potential effects
of medication.
Supplementary information
Supplementary information accompanies this paper at https://doi.org/10.
1186/s13148-020-00890-w.
Additional file 1: Supplementary material. Evaluation of Normality
for DNA methylation levels of CpG sites. Supplementary Fig. 1.
Histograms of the variables of the CpG sites for each group in males and
females. Table S1. Results of MANCOVAa of DNA methylation at OXTR
CpG sites between drug-naïve patients with OCD and drug-treated pa-
tients with OCD for men and women. Table S2. Partial correlationa be-
tween DNA methylation levels at OXTR1 CpG1 and CpG2 and OC
symptom dimensions based on OCI-R-K in drug-naïve patients with OCD
(n = 45)
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